Research Project
S Crabb: Alliance with Plexxikon: A phase Ib/IIa trial to combine the CSF1 receptor inhibitor PLX3397 with the new generation AR antagonist enzalutamide in metastatic castration resistant prostate cancer
https://www.southampton.ac.uk/research/projects/s-crabb-alliance-with-plexxikon-a-phase-ibiia-trial-to-combine-the-csf1-receptor